ABOUT US
Audacia Bioscience was founded in 2016 by Phillip Olla PhD and Dr Stephen Bartol. We are passionate about developing digital solutions that solve challenges within the healthcare domain, using Artificial Technology (AI), sensor and lateral flow technology.
Audacia Bioscience has a strong team of seasoned and proven professionals with medical and digital health expertise.
Our work during the pandemic led to the development of both COVID-19 Antibody, and COVID-19 Antigen tests, as well as virtual clinical trial software, that served as a key tool to provide the remote collection of the data necessary to understand the pandemic.
Virtual Clinical Trial Data Collection
The freedom of minimal intervention with maximum interaction using quantitative dried blood Spots, saliva and breath collection techniques.
Robust Data Management and Dashboards
All studies and testing data benefit from continual real-time access in an easy to use format.
Knowledge Translation
We create scholarly publications disseminating knowledge to the scientific community, and consumer level knowledge dissemination using our AI Chatbot.
Evidence Generating Solution
Our solution is powered by algorithmic AI generating clinical evidence-driven results.
OUR SERVICES
Exhaled Breath Research
Experts in multi device breath collection and analysis for drug and medical research
Assure Covid Clinic
We provide services for corporate clients, event planners and travel agents to ensure smooth travelling
AI Meta analysis
AI meta-analysis is a transparent multiple study scientific statistical analysis
AI Literature Research
AI Generated systematic, transparent overview of literature on a topic
20K
Tests performed
63
Corporate Clients
200+
Scientific Publications
12
Happy Staff
Funding and Strategic Partners
Audacia Bioscience has been privileged to receive funding from the Canadian Federal and Provincial government to support our research initiatives.
